K. Zehrouni

Non-Ambulant Duchenne Patients Theoretically Treatable by Exon 53 Skipping have Severe Phenotype

L. Servais, J. Hogrel, F. Leturcq, 2015, Journal of neuromuscular diseases.

P.20.14 Non ambulant patients with deletion treatable by exon skipping 53 present a more severe phenotype than the general Duchenne population

L. Servais, F. Leturcq, P. Sabouraud, 2013, Neuromuscular Disorders.

Pregnancy in congenital myasthenic syndrome

L. Servais, B. Eymard, T. Stojkovic, 2013, Journal of Neurology.